← Leaderboards
Bela Anand-Apte
Cleveland Clinic Foundation
$12,006,070
Attributed
$12,374,660
Total exposure
10
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$18,130,666 · 11
By mechanism
R01$10,625,874 · 5
P30$5,869,116 · 3
T32$1,011,693 · 1
R29$313,338 · 1
R41$310,645 · 1
Top collaborators
- Joe Gilbert Hollyfield5 shared
Most similar at Cleveland Clinic Foundation
Same institution · by research overlap
- Joe Gilbert Hollyfield$7,576,094
- Lihua Y Marmorstein$4,133,800
- John W Crabb$6,129,227
- Suneel S Apte$12,134,117
- Kang Zhang$12,829,337
Others in their field
Top investigators on “Blindness”
- Randall J Bateman · Washington University$137,189,188
- John M Lachin · George Washington University$122,970,601
- David M Nathan · Massachusetts Institute Of Technology$118,921,924
- Beth Baseler · Leidos Biomedical Research, Inc.$111,479,515
- Judith S Hochman · New York University School Of Medicine$100,149,457
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$96,562,493
Research focus
BlindnessMolecularBaseVisionPlayPreventRetinaFundingPhysiologicalCellsReportingLaboratoriesGenesVision ScienceTechnologyIn VivoInstitutesMediatingGrantAngiogenesis InhibitorsCenter Core GrantsMutantInstitutionCore Grant
Grant awards (55)
NEI Center Core Grant for Vision Research$644,002
P30 · FY2025 · EY · contact PI
Cole Eye Institute Vision Science Training Program$81,513
T32 · FY2025 · EY · contact PI
CORE A - Administrative Core$22,622
P30 · FY2025 · EY · contact PI
NEI Center Core Grant for Vision Research$644,002
P30 · FY2024 · EY · contact PI
FGF and hyaluronan-mediated alterations in epithelial-mesenchymal transition and metabolism of RPE cells in Sorsby Fundus Dystrophy.$609,084
R01 · FY2024 · EY · contact PI
Cole Eye Institute Vision Science Training Program$89,560
T32 · FY2024 · EY · contact PI
CORE A - Administrative Core$22,622
P30 · FY2024 · EY · contact PI
NEI Center Core Grant for Vision Research$644,001
P30 · FY2023 · EY · contact PI
FGF and hyaluronan-mediated alterations in epithelial-mesenchymal transition and metabolism of RPE cells in Sorsby Fundus Dystrophy.$610,140
R01 · FY2023 · EY · contact PI
Cole Eye Institute Vision Science Training Program$36,248
T32 · FY2023 · EY · contact PI
CORE A - Administrative Core$22,622
P30 · FY2023 · EY · contact PI
NEI Center Core Grant for Vision Research$644,001
P30 · FY2022 · EY · contact PI
FGF and hyaluronan-mediated alterations in epithelial-mesenchymal transition and metabolism of RPE cells in Sorsby Fundus Dystrophy.$621,747
R01 · FY2022 · EY · contact PI
CORE A - Administrative Core$22,622
P30 · FY2022 · EY · contact PI
Cole Eye Institute Vision Science Training Program$1,547
T32 · FY2022 · EY · contact PI
FGF and hyaluronan-mediated alterations in epithelial-mesenchymal transition and metabolism of RPE cells in Sorsby Fundus Dystrophy.$656,227
R01 · FY2021 · EY · contact PI
NEI Center Core Grant for Vision Research$644,000
P30 · FY2021 · EY · contact PI
Cole Eye Institute Vision Science Training Program$65,644
T32 · FY2021 · EY · contact PI
CORE A - Administrative Core$22,622
P30 · FY2021 · EY · contact PI
NEI CENTER CORE GRANT FOR VISION RESEARCH$634,000
P30 · FY2020 · EY · contact PI
Role of Retinoic Acid in the Regulation of the Blood-Retinal Barrier.$413,016
R01 · FY2020 · EY · contact PI
Regulation of Choroidal Neovascularization in Sorsby's Fundus Dystrophy$396,250
R01 · FY2020 · EY · contact PI
NEI CENTER CORE GRANT FOR VISION RESEARCH$634,000
P30 · FY2019 · EY · contact PI
Role of Retinoic Acid in the Regulation of the Blood-Retinal Barrier.$413,016
R01 · FY2019 · EY · contact PI
Regulation of Choroidal Neovascularization in Sorsby's Fundus Dystrophy$396,250
R01 · FY2019 · EY · contact PI
Cole Eye Institute Vision Science Training Program$135,752
T32 · FY2019 · EY · contact PI
NEI CENTER CORE GRANT FOR VISION RESEARCH$634,000
P30 · FY2018 · EY · contact PI
Role of Retinoic Acid in the Regulation of the Blood-Retinal Barrier.$413,016
R01 · FY2018 · EY · contact PI
Regulation of Choroidal Neovascularization in Sorsby's Fundus Dystrophy$356,625
R01 · FY2018 · EY · contact PI
Cole Eye Institute Vision Science Training Program$132,736
T32 · FY2018 · EY · contact PI
NEI CENTER CORE GRANT FOR VISION RESEARCH$634,000
P30 · FY2017 · EY · contact PI
Role of Retinoic Acid in the Regulation of the Blood-Retinal Barrier.$413,016
R01 · FY2017 · EY · contact PI
Regulation of Choroidal Neovascularization in Sorsby's Fundus Dystrophy$356,625
R01 · FY2017 · EY · contact PI
Cole Eye Institute Vision Science Training Program$126,017
T32 · FY2017 · EY · contact PI
Role of Retinoic Acid in the Regulation of the Blood-Retinal Barrier.$413,016
R01 · FY2016 · EY · contact PI
Cole Eye Institute Vision Science Training Program$174,023
T32 · FY2016 · EY · contact PI
Cole Eye Institute Vision Science Training Program$168,653
T32 · FY2015 · EY · contact PI
Role of betacellulin in diabetic macular edema$384,650
R01 · FY2014 · EY · contact PI
Role of betacellulin in diabetic macular edema$372,875
R01 · FY2013 · EY · contact PI
Role of betacellulin in diabetic macular edema$392,500
R01 · FY2012 · EY · contact PI
Role of betacellulin in diabetic macular edema$392,500
R01 · FY2011 · EY · contact PI
Role of TIMP-3 in Ocular Neovascularization$331,022
R01 · FY2009 · EY · contact PI
Inhibition of VEGF Mediated Angiogenesis by TIMP-3$289,326
R01 · FY2009 · CA · contact PI
Role of TIMP-3 in Ocular Neovascularization$327,593
R01 · FY2008 · EY · contact PI
Inhibition of VEGF Mediated Angiogenesis by TIMP-3$265,216
R01 · FY2008 · CA · contact PI
Role of TIMP-3 in Ocular Neovascularization$334,279
R01 · FY2007 · EY · contact PI
CAN CD 133 CELLS PREVENT HYPOXIA DRIVEN RETINAL NEOVASCULARISATION IN A RODENT MO$310,645
R41 · FY2007 · EY · contact PI
Inhibition of VEGF Mediated Angiogenesis by TIMP-3$260,393
R01 · FY2007 · CA · contact PI
Role of TIMP-3 in Ocular Neovascularization$336,161
R01 · FY2006 · EY · contact PI
Inhibition of VEGF Mediated Angiogenesis by TIMP-3$268,170
R01 · FY2006 · CA · contact PI
Role of TIMP-3 in Ocular Neovascularization$356,000
R01 · FY2005 · EY
Inhibition of VEGF Mediated Angiogenesis by TIMP-3$247,161
R01 · FY2005 · CA
REGULATION OF RETINAL NEOVASCULARIZATION BY TIMP3$107,548
R29 · FY2002 · EY
REGULATION OF RETINAL NEOVASCULARIZATION BY TIMP3$104,416
R29 · FY2001 · EY
REGULATION OF RETINAL NEOVASCULARIZATION BY TIMP3$101,374
R29 · FY2000 · EY